VALBIOTIS (EPA:ALVAL) | Finanzwire

Basculer en Français

11006	Companies
241133	Keywords
169708	Articles
129806	Press releases

Home
Companies
VALBIOTIS

PRESS RELEASE

published on 01/26/2026 at 17:40, 7 months 21 days ago

VALBIOTIS SA: Valbiotis launches an exclusive commercial benefit for its shareholders: a 20% discount on ValbiotisPRO® and ValbiotisPLUS® ranges
Valbiotis launches a 20% discount on ValbiotisPRO® and ValbiotisPLUS® ranges exclusively for its shareholders, strengthening the link with them and rewarding their commitment

Shareholders Valbiotis Discount Health Supplements
BRIEF

published on 01/19/2026 at 17:50, 7 months 28 days ago

Half-year review of Valbiotis' liquidity contract

Liquidity Contract AMF PORTZAMPARC Valbiotis Securities And Euros
BRIEF

published on 01/19/2026 at 17:50, 7 months 28 days ago

Valbiotis Liquidity Contract Half-Yearly Report

Securities Liquidity Contract Transactions PORTZAMPARC Valbiotis
BRIEF

published on 01/19/2026 at 17:50, 7 months 28 days ago

VALBIOTIS SA: Information on voting rights and shares as of December 31, 2025

Voting Rights Actions Euronext Growth Valbiotis Participation Thresholds
BRIEF

published on 01/12/2026 at 17:45, 8 months 4 days ago

Valbiotis publishes scientific advances on TOTUM-448

Valbiotis Metabolic Diseases Bioavailability TOTUM-448 Scientific Reports
BRIEF

published on 01/12/2026 at 17:45, 8 months 4 days ago

Valbiotis Publishes New Study on TOTUM-448 for MASLD

Valbiotis Bioavailability MASLD TOTUM-448 Scientific Publication
PRESS RELEASE

published on 01/12/2026 at 17:40, 8 months 4 days ago

VALBIOTIS SA: Valbiotis announces a major new scientific publication on TOTUM-448, an active substance designed to treat metabolic liver disease (MASLD)
Valbiotis announces publication in Scientific Reports on TOTUM-448, active substance for metabolic liver disease, presenting results from human study

Valbiotis Bioavailability TOTUM-448 Scientific Publication Metabolic Liver Disease
BRIEF

published on 01/08/2026 at 17:45, 8 months 8 days ago

Valbiotis signs an exclusive distribution agreement in the Middle East

Middle East Partnership Valbiotis Dietary Supplements Distribution
BRIEF

published on 01/08/2026 at 17:45, 8 months 8 days ago

Valbiotis Enters Middle East Market with Exclusive Distribution Deal

Distribution Agreement Middle East Valbiotis International Expansion Cardiometabolic Prevention
PRESS RELEASE

published on 01/08/2026 at 17:40, 8 months 8 days ago

VALBIOTIS SA: Valbiotis announces an exclusive distribution agreement in the Middle East
Valbiotis signs exclusive distribution agreement with Mena Nutrition in Middle East, expanding international reach. Products to focus on cardiometabolic conditions prevention

Distribution Agreement Middle East Valbiotis Mena Nutrition Cardiometabolic Conditions

Accesswire

Published on 09/16/2026 at 23:45, 5 hours 21 minutes ago

Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 7 hours 36 minutes ago

Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 12 hours 11 minutes ago

CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 14 hours 6 minutes ago

2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 15 hours 6 minutes ago

Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update

View all ACCESSWIRE

EQS Group

Published on 09/17/2026 at 04:25, 40 minutes ago

Zhou Jianjun from Huawei: Building a Grid-Interactive AIDC Solution to Maximize Tokens Per Watt
Published on 09/16/2026 at 23:45, 5 hours 20 minutes ago

WESCAN GOLDFIELDS COMMENCES UAV MAGNETIC AND LIDAR SURVEYS AT MUNRO LAKE PROJECT
Published on 09/16/2026 at 22:33, 6 hours 32 minutes ago

EQS-Adhoc: Bilfinger adjusts outlook for 2026 and resolves program “Agile”
Published on 09/16/2026 at 21:15, 7 hours 50 minutes ago

Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals
Published on 09/16/2026 at 20:27, 8 hours 38 minutes ago

EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million

Les Echos

Published on 09/16/2026 at 20:46, 8 hours 19 minutes ago

LNA SANTE : 2026 First Half Results
Published on 09/16/2026 at 17:45, 11 hours 21 minutes ago

5th edition of “On the way up” show
Published on 09/16/2026 at 17:45, 11 hours 21 minutes ago

Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 22 hours 6 minutes ago

bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 11 hours ago

Report on the Combined General Meeting of the 10th of September 2026

View all LES ECHOS COMFI WIRE